![Icon of a document with a pencil](https://www.catalent.com/wp-content/uploads/2019/08/article.png)
Developing Optimised Formulations with Minimal Drug Substance
Summary: Advances in in silico and experimental techniques mean that APIs and prototype formulations can be thoroughly characterised using multiple material-sparing assays, allowing the most promising formulation candidates to move on to in vivo studies.